Cardiol Therapeutics is a company that produces pharmaceutical cannabidiol and develops cannabidiol medicines for heart disease. It provides CardiolRx, a formulation designed to address acute myocarditis and other causes of heart failure. The company is also engaged in the development of nanotechnology to deliver pharmaceutical cannabidiol and other anti-inflammatory drugs directly to sites of inflammation in the heart.